Andlauer Healthcare Group Inc.

AND.TOTSXIndustrials

$54.97

+$0.00(+0.00%)

Market Cap$2.2B

P/E Ratio—

52W High$55.1

52W Low$36.68

Avg Volume45K

Open$54.98

Beta0.87

Free Cash Flow Financials Revenue

Andlauer Healthcare Group Inc. (AND.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AND.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

AND.TO · FCF · TTM · margin & CAGR

Free cash flow was $104.0M for FY2024 (fiscal year ending 2024-12-31), up 32.0% year-over-year The FCF margin was 16.0%. Five-year CAGR stands at +13.7%.

FY2024 Free Cash Flow$104.0M▲ +32.0% YoY

Trailing 12M (TTM)$100.3Mtrailing 4 quarters sum

FCF Margin16.0%$104.0M ÷ revenue

3-Year CAGR+11.8%FY2021 → FY2024

5-Year CAGR+13.7%FY2019 → FY2024

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

AND.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$124.4M(20M)$104.0M▲ +32.0%16.0%

FY2023$104.4M(26M)$78.8M▼ 27.8%12.2%

FY2022$137.1M(28M)$109.2M▲ +46.7%16.8%

FY2021$84.1M(10M)$74.4M▲ +63.3%16.9%

FY2020$51.0M(5M)$45.6M▼ 16.9%14.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

AND.TO · P/FCF · FCF yield · FCF per share

Andlauer Healthcare Group Inc. (AND.TO) trades at a FCF yield of 3.43% and a price-to-free-cash-flow ratio of 22.1x. FCF per share stands at $2.49, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.43%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.49

TTM FCF ÷ Shares Outstanding

Price / FCF

x22.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x30.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

AND.TO · cash flow statement · operating / investing / financing

For FY2024, Andlauer Healthcare Group Inc. generated $124.4M in operating cash flow and spent 20M in capital expenditures, yielding $104.0M in free cash flow.

Operating Activities

+$124.4M

Cash from core business operations

2024-12-31

Investing Activities

−$18.9M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

−$126.2M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF ($124.4M) − |CapEx| (20M) = FCF ($104.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Industrials)

AND.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Andlauer Healthcare Group Inc.YOU

AND.TO

$104.0M+32.0%16.0%

Union Pacific Corporation

Industrials · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Andlauer Healthcare Group Inc. (AND.TO) reported free cash flow of $104.0M for FY2024 (fiscal year ending 2024-12-31), up 32.0% year-over-year. The FCF margin was 16.0%.

Based on available data, Andlauer Healthcare Group Inc. has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $109.2M in FY2022. The 5-year CAGR stands at +13.7%.

Andlauer Healthcare Group Inc.'s FCF yield is 3.43% and price-to-FCF ratio is 22.1x for FY2024, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

AND.TO free cash flow · 8 questions

Andlauer Healthcare Group Inc. free cash flow was $104.0M for FY2024, up 32.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $100.3M.

AND.TO free cash flowAND.TO FCFAND.TO FCF 2024AND.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Andlauer Healthcare Group Inc. · Andlauer Healthcare Group Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026